FTAC ZEUS SPONSOR LLC - 23 Nov 2021 Form 4 Insider Report for FTAC ZEUS ACQUISITION CORP.

Role
10%+ Owner
Signature
/s/ Daniel G. Cohen, Manager
Issuer symbol
N/A
Transactions as of
23 Nov 2021
Net transactions value
+$787,500
Form type
4
Filing time
24 Nov 2021, 16:01:48 UTC
Previous filing
18 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZING Class A common stock Other $787,500 +78,750 +4.6% $10.00 1,778,750 23 Nov 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZING Warrants Other $0 +39,375 +4.6% $0.000000 889,375 23 Nov 2021 Class A Common Stock 39,375 $11.50 Direct F1, F3, F4
holding ZING Class B Common Stock 7,215,000 23 Nov 2021 Class A Common Stock 7,215,000 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquisition by reporting person in connection with the full exercise of the underwriter's over-allotment option.
F2 These shares underlie the same number of units of the issuer held by the reporting person.
F3 The warrants will become exercisable 30 days after the consummation of the issuer's initial business combination.
F4 The warrants will expire five years after the consummation of the issuer's initial business combination or earlier upon redemption of all of the issuer's outstanding Class A common shares or the issuer's liquidation.
F5 The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
F6 Represents shares of Class B common stock held by the reporting person after full exercise of the underwriter's over-allotment option.